Amylyx Pharmaceuticals Inc (AMLX)
1.93
+0.12
(+6.63%)
USD |
NASDAQ |
May 01, 16:00
1.93
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Total Assets (Quarterly): 517.45M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 517.45M |
| September 30, 2023 | 466.58M |
| June 30, 2023 | 453.59M |
| March 31, 2023 | 407.96M |
| December 31, 2022 | 391.45M |
| September 30, 2022 | 181.44M |
| Date | Value |
|---|---|
| June 30, 2022 | 225.24M |
| March 31, 2022 | 274.44M |
| December 31, 2021 | 105.61M |
| September 30, 2021 | 130.46M |
| December 31, 2020 | 14.10M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
14.10M
Minimum
Dec 2020
517.45M
Maximum
Dec 2023
288.03M
Average
274.44M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| Cassava Sciences Inc | 151.66M |
| iRhythm Technologies Inc | 433.14M |
| Bristol-Myers Squibb Co | 99.03B |
| Moderna Inc | 18.43B |
| ACADIA Pharmaceuticals Inc | 748.96M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 84.02M |
| Shareholders Equity (Quarterly) | 433.43M |
| Current Ratio | 5.664 |